AbbVie Current Ratio 2010-2020 | ABBV

Current and historical current ratio for AbbVie (ABBV) from 2010 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. AbbVie current ratio for the three months ending March 31, 2020 was 3.14.
AbbVie Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $51.76B $16.47B 3.14
2019-12-31 $49.52B $15.59B 3.18
2019-09-30 $20.17B $17.49B 1.15
2019-06-30 $15.10B $16.94B 0.89
2019-03-31 $14.41B $13.90B 1.04
2018-12-31 $16.95B $17.24B 0.98
2018-09-30 $18.47B $15.39B 1.20
2018-06-30 $13.85B $17.22B 0.80
2018-03-31 $20.44B $17.06B 1.20
2017-12-31 $21.22B $16.64B 1.28
2017-09-30 $18.93B $13.03B 1.45
2017-06-30 $16.96B $12.26B 1.38
2017-03-31 $15.55B $8.84B 1.76
2016-12-31 $16.19B $9.78B 1.66
2016-09-30 $16.29B $9.10B 1.79
2016-06-30 $16.79B $9.27B 1.81
2016-03-31 $16.62B $10.66B 1.56
2015-12-31 $16.31B $10.89B 1.50
2015-09-30 $17.91B $8.81B 2.03
2015-06-30 $16.88B $11.26B 1.50
2015-03-31 $15.41B $11.05B 1.39
2014-12-31 $16.08B $11.39B 1.41
2014-09-30 $17.56B $6.64B 2.65
2014-06-30 $17.79B $6.32B 2.82
2014-03-31 $17.33B $6.22B 2.79
2013-12-31 $17.85B $6.88B 2.60
2013-09-30 $16.54B $6.88B 2.41
2013-06-30 $15.66B $6.81B 2.30
2013-03-31 $14.92B $6.77B 2.21
2012-12-31 $15.35B $6.78B 2.27
2012-09-30 $10.93B $5.37B 2.04
2012-06-30 $5.99B $4.84B 1.24
2012-03-31 $6.75B $5.52B 1.22
2011-12-31 $7.35B $5.90B 1.25
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $8.22B $3.76B 2.19
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $144.632B $33.266B
AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie aims to help patients' live healthier lives and collaborate on sustainable healthcare solutions.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $375.403B 16.05
Roche Holding AG (RHHBY) Switzerland $304.758B 0.00
Novartis AG (NVS) Switzerland $199.895B 15.62
Merck (MRK) United States $193.573B 14.02
Pfizer (PFE) United States $185.865B 11.54
Eli Lilly (LLY) United States $159.201B 25.77
Novo Nordisk (NVO) Denmark $154.498B 25.73
AstraZeneca (AZN) United Kingdom $141.637B 29.17
Sanofi (SNY) $126.584B 14.65
GlaxoSmithKline (GSK) United Kingdom $101.269B 12.09
Bayer (BAYRY) Germany $66.771B 9.52
H Lundbeck (HLUYY) Denmark $7.524B 13.07
Innoviva (INVA) United States $1.376B 7.94